"10.1371_journal.pone.0046356","plos one","2012-10-16T00:00:00Z","Jan-Willem E M Sels; Ellen H A M Elsenberg; Imo E Hoefer; Anton Jan van Zonneveld; Johan Kuiper; J Wouter Jukema; Nico H J Pijls; Gerard Pasterkamp","Department of Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands; Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands; Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands; Division of Biopharmaceuticals, Leiden University, Leiden, The Netherlands; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands","Conceived and designed the experiments: JS EE GP IH JJ NP. Performed the experiments: JS EE. Analyzed the data: JS EE IH. Contributed reagents/materials/analysis tools: JK AvZ EE. Wrote the paper: JS EE GP NP.","The authors have read the journals policy and have the following potential conflicts: GP is founder of Cavadis, a biomarker company. There is no association with the content of this paper. JJ has received research grants from and was speaker on (CME accredited) meetings sponsored by Astellas, Astra-Zeneca, Bayer, Biotronik, Boston Scientific, Daiichi Sankyo, Lilly, Genzyme, Medtronic, Merck-Schering-Plough, Pfizer, Orbus Neich, Novartis, Roche, Servier, Sanofi Aventis, the Netherlands Heart Foundation, the Interuniversity Cardiology Institute of the Netherlands and the European Community Framework KP7 Programme. NHJP has received research grants from St Jude Medical, Abbott and Maquet and is a consultant for St Jude Medical. Other authors have no potential conflicts to disclose.","2012","10","Jan-Willem E M Sels","JWEMS",8,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
